Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Notes Payables (2016 - 2025)

Skinvisible's Notes Payables history spans 14 years, with the latest figure at $352075.0 for Q3 2025.

  • For Q3 2025, Notes Payables fell 12.37% year-over-year to $352075.0; the TTM value through Sep 2025 reached $352075.0, down 12.37%, while the annual FY2023 figure was $40000.0, 0.0% changed from the prior year.
  • Notes Payables for Q3 2025 was $352075.0 at Skinvisible, roughly flat from $352075.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $2.8 million in Q3 2022 and bottomed at $40000.0 in Q4 2022.
  • The 5-year median for Notes Payables is $382611.5 (2024), against an average of $1.1 million.
  • The largest annual shift saw Notes Payables surged 1658.77% in 2021 before it plummeted 98.59% in 2023.
  • A 5-year view of Notes Payables shows it stood at $2.4 million in 2021, then plummeted by 98.32% to $40000.0 in 2022, then changed by 0.0% to $40000.0 in 2023, then skyrocketed by 904.4% to $401761.0 in 2024, then decreased by 12.37% to $352075.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Notes Payables are $352075.0 (Q3 2025), $352075.0 (Q2 2025), and $352075.0 (Q1 2025).